Weiss Multi-Strategy Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-90,000	Closed	-$5.8M	–	448
2015 Q1	$5.8M	Buy	+90,000	New	+$5.63M	0.26%	106

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Weiss Multi-Strategy Advisers's BMY Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 45,904 shares — an estimated $2.35M sold.

Weiss Multi-Strategy Advisers first reported a position in BMY in Q2 2013 and held it in 37 quarters. The position peaked at $16.6M in Q4 2021. 2,331 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 45,904 Bristol-Myers Squibb shares in Q1 2024, an estimated $2.35M.
Weiss Multi-Strategy Advisers first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 37 quarters.
Weiss Multi-Strategy Advisers's Bristol-Myers Squibb position peaked at $16.6M in Q4 2021.
2,331 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.